abstract |
The present invention relates to a compound of formula (I): And salts and solvates thereof. The compound represented by the formula (I) is an adenosine A 2A receptor agonist and is expected to be used in the treatment of inflammatory diseases such as asthma and chronic obstructive pulmonary disease. |